Država: Nova Zelandija
Jezik: angleščina
Source: Medsafe (Medicines Safety Authority)
Levonorgestrel 0.75mg
Teva Pharma (New Zealand) Limited
Levonorgestrel 0.75 mg
0.75 mg
Tablet
Active: Levonorgestrel 0.75mg Excipient: Colloidal silicon dioxide Lactose monohydrate Magnesium stearate Maize starch Povidone Sunset yellow FCF
Blister pack, PVC/Aluminium 2 tablet within a cardboard tri-fold sleeve. 5 sleeves per pack, 10 tablets
Prescription
Prescription
ScinoPharm Taiwan Ltd
NEXT CHOICE is an oral emergency contraceptive indicated for use within 72 hours of unprotected intercourse. It should be used only as an emergency measure. Women who present for repeated courses of emergency contraception should be advised to consider long-term methods of contraception.
Package - Contents - Shelf Life: Blister pack, PVC/Aluminium 2 tablet within a cardboard tri-fold sleeve. 5 sleeves per pack - 10 tablets - 24 months from date of manufacture stored at or below 25°C
2011-06-16
NEXT CHOICE LEVONORGESTREL 750 MCG TABLETS WHAT IS IN THIS LEAFLET Please read this leaflet carefully before you take NEXT CHOICE. This leaflet answers some common questions about NEXT CHOICE. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the risks of you using NEXT CHOICE against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, TALK TO YOUR DOCTOR OR PHARMACIST. Keep this leaflet with your medicine. You may need to read it again. WHAT NEXT CHOICE IS USED FOR NEXT CHOICE is an emergency contraceptive that can be used after unprotected sex or where a contraceptive method has failed. This type of contraception is often called "the morning-after pill". Each pack contains two round, peach coloured tablets. Each tablet contains 750 micrograms of levonorgestrel, which is the active ingredient. _HOW DOES NEXT CHOICE WORK? _ NEXT CHOICE is an emergency contraceptive which is taken after unprotected sex. It is thought to work by: • Stopping your ovaries from releasing an egg; • Preventing sperm from fertilising any egg you may have already released; or • Stopping a fertilised egg from attaching itself to your womb lining. NEXT CHOICE helps to stop a pregnancy before it is established. It does not work if you are already pregnant. NEXT CHOICE can help to prevent you from getting pregnant, but you must take the first tablet within 72 hours (three days) of having unprotected sex. The tablets are more effective if they are taken as soon as possible after unprotected sex. You need to take the Preberite celoten dokument
NEXT CHOICE LEVONORGESTREL TABLETS 750MCG PRESENTATION NEXT CHOICE 750mcg Tablets: Round, peach, uncoated tablets debossed ‘475’ on one side and ‘WATSON’ on the other side. Each tablet contains 750mcg levonorgestrel. USES _ACTIONS _ The precise mode of action of NEXT CHOICE is not known. At the recommended regimen, levonorgestrel is thought to work mainly by preventing ovulation and fertilisation if the intercourse has taken place in the preovulatory phase, when the likelihood of fertilisation is the highest. NEXT CHOICE may also cause endometrial changes that discourage implantation. NEXT CHOICE is not effective once the process of implantation has begun. At the recommended regimen, levonorgestrel is not expected to induce significant modification of blood clotting factors, and lipid and carbohydrate metabolism. It has been estimated that levonorgestrel 750mcg (2 tablets 12 hours apart) prevents 85% of expected pregnancies. Efficacy appears to decline with time after intercourse (95% within 24 hours, 85% if used between 24 and 48 hours and/or 58% if used between 48 and 72 hours). Efficacy after 72 hours is unknown. _PHARMACOKINETICS _ Orally administered levonorgestrel is rapidly and almost completely absorbed. Following ingestion of one tablet of levonorgestrel 750mcg tablet, maximum drug serum levels of 14.1 ng/ml were found at 1.6 hours. Thereafter, levonorgestrel serum levels decrease in two disposition phases with mean elimination half-lives which range from about 9 hours to 14.5 hours. Levonorgestrel is not excreted in unchanged form but as metabolites. Levonorgestrel metabolites are excreted in about equal proportions with urine and faeces. The biotransformation follows the known pathways of steroid metabolism; levonorgestrel is hydr Preberite celoten dokument